Research Publication – Protein Design for Targeted Therapeutics

Virvio co-founders publish Nature article- Dr. Merika Koday, Dr. Aaron Chevalier, Prof. Deborah Fuller, and Prof. David Baker have co-authored a new article in Nature describing the design and selection process for thousands of high affinity minibinders against two distinct therapeutic targets. This is the first published demonstration of our platform minibinder design process. (http://www.nature.com/nature/journal/vaop/ncurrent/full/nature23912.html)